Table 1.
Characteristic | Biologic-naïve RA (n = 8) | Non-RA control (n = 10) | P-value* |
---|---|---|---|
Age, years, mean | 55.1 (16.5) | 53.2 (16.0) | 0.81 |
Female, % | 62.5% | 70.0% | 1.0 |
Race+, % | |||
Caucasian Non-Caucasian African American Hispanic Indian Unknown |
50% 50% 25% 12.5% 12.5% 0% |
30% 70% 10% 10% 0% 50% |
0.63 |
BMI (kg/m2) | 32.6 | – | |
Diabetes mellitus | 0% | – | |
Smoking history | |||
Current | 12.5% | – | |
Former | 37.5% | – | |
Never | 50% | – | |
RA disease characteristics | |||
Remission, % | 75% | – | – |
Autoantibody status | |||
RF positive, % | 75% | – | – |
ACPA positive, % | 75% | – | – |
ESR mm/h, mean | 23.38 (17.73) | – | – |
CRP mg/L, mean | 4.26 (1.64) | – | – |
RAPID3 score, mean | 10.42 (5.71) | – | – |
Medication history | |||
DMARDs, % | 100% | – | – |
Glucocorticoids, % | 0% | – | – |
Biologic agents | |||
TNF-inhibitor, % | 0% | – | – |
Other, % | 0% | – | – |
Number of caries, mean | 3 (3.85) | 4.4 (7.07) | 0.62 |
Probing depth, mean (mm) | |||
Shallow sites (PD ≤ 3 mm) | 2.58 | 2.08 | 0.02 |
Deep sites (PD ≥ 4 mm) $ | 4.00 | 3.65 | 0.47 |
Global PD status | |||
Healthy, % | 12.5% | 0% | 0.54 |
Periodontitis stage I, % | 37.5% | 40% | |
Periodontitis stage II, % | 12.5% | 40% | |
Periodontitis stage III, % | 37.5% | 20% |
RF, rheumatoid factor; ACPA, anti-cyclic citrullinated protein antibody; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; RAPID3, routine assessment of patient index data 3; DMARD, disease modifying antirheumatic drug; TNF, tumor necrosis factor; PD, periodontal disease. Periodontitis stages are described elsewhere [8, 28]
*Age and pocket depth were compared using Student’s t-test. All other parameters were compared using Fisher’s Exact test. P-value in race was calculated with Caucasian vs. non-Caucasian data. Standard deviation is shown in parentheses
+Race was self-reported
$Probing depths were averaged measurements from the facial and/or lingual sites from which subgingival samples were collected